Chief Executive Officer
Maris Hartmanis was born in 1953. He gained a PhD in Biochemistry and Associate Professor at the Royal Institute of Technology, Stockholm. He was president and CEO at Medivir and CEO of BioPhausia. He has worked for Medivir since 2011. Mr Hartmanis has more than 25 years within the Life Science industry in senior positions at companies like BioPhausia, Gambro, Amersham and Pharmacia. Medivir shareholding: 35,000 class B.